CTTH CEO Buys 7,700 Shares in Open-Market Purchase

What Happened
The company's CEO (name not specified in the filing) made an open-market purchase on 2026-08-07, acquiring 7,700 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.07 per share for a total reported cost of $501. This was a straight purchase (transaction code P), which is generally viewed as a more informative (bullish) signal than routine sales.

Key Details

• Transaction date: 2026-08-07
• Transaction type: Open-market purchase (code P)
• Shares acquired: 7,700 shares at $0.07 per share
• Total value: $501 (as reported)
• Shares owned after the transaction: Not reported in this filing
• Filing date: 2026-08-10 — no late filing indicator noted in the filing
• Footnotes/conditions: None disclosed in the reported transaction

Context
Purchases by company insiders can indicate confidence but are not proof of future performance. This was a small, low-dollar purchase; retail investors should weigh it alongside other data (company fundamentals, news, and broader insider activity) before drawing conclusions.